Articles:

The role of DNA mismatch repair in drug resistance

D Fink, S Aebi, and SB Howell
Clin Cancer Res 1998 4: 1 [Abstract] [PDF]  

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study

RM Elledge, S Green, D Ciocca, R Pugh, DC Allred, GM Clark, J Hill, P Ravdin, J O'Sullivan, S Martino, and CK Osborne
Clin Cancer Res 1998 4: 7 [Abstract] [PDF]  

Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma

JR Grandis, DJ Tweardy, and MF Melhem
Clin Cancer Res 1998 4: 13 [Abstract] [PDF]  

CD44 expression in the stromal matrix of colorectal cancer: association with prognosis

K Furuta, M Zahurak, SN Goodman, SR Hamilton, and JT August
Clin Cancer Res 1998 4: 21 [Abstract] [PDF]  

Expression of intercellular adhesion molecule-1 in invasive breast cancer reflects low growth potential, negative lymph node involvement, and good prognosis

Y Ogawa, K Hirakawa, B Nakata, T Fujihara, T Sawada, Y Kato, K Yoshikawa, and M Sowa
Clin Cancer Res 1998 4: 31 [Abstract] [PDF]  

Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal

N Dawson, WD Figg, OW Brawley, R Bergan, MR Cooper, A Senderowicz, D Headlee, SM Steinberg, M Sutherland, N Patronas, E Sausville, WM Linehan, E Reed, and O Sartor
Clin Cancer Res 1998 4: 37 [Abstract] [PDF]  

Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group

VI Avramis, S Wiersma, MD Krailo, LV Ramilo-Torno, A Sharpe, W Liu-Mares, R Kowck, GH Reaman, and JK Sato
Clin Cancer Res 1998 4: 45 [Abstract] [PDF]  

A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancer

GR Weiss, I Poggesi, M Rocchetti, D DeMaria, T Mooneyham, D Reilly, LV Vitek, F Whaley, E Patricia, DD Von Hoff, and P O'Dwyer
Clin Cancer Res 1998 4: 53 [Abstract] [PDF]  

Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study

SC Srivastava, HL Atkins, GT Krishnamurthy, I Zanzi, EB Silberstein, G Meinken, LF Mausner, F Swailem, T D'Alessandro, CJ Cabahug, Y Lau, T Park, and S Madajewicz
Clin Cancer Res 1998 4: 61 [Abstract] [PDF]  

Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia

R Riccardi, A Riccardi, A Lasorella, T Servidei, and S Mastrangelo
Clin Cancer Res 1998 4: 69 [Abstract] [PDF]  

Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma

E Bajetta, M Del Vecchio, R Mortarini, R Nadeau, A Rakhit, L Rimassa, C Fowst, A Borri, A Anichini, and G Parmiani
Clin Cancer Res 1998 4: 75 [Abstract] [PDF]  

Apoptotic tumor cell death induced by estramustine in patients with malignant glioma

C Vallbo, AT Bergenheim, P Bergstrom, PO Gunnarsson, and R Henriksson
Clin Cancer Res 1998 4: 87 [Abstract] [PDF]  

Detection of germ cell tumor cells in apheresis products using polymerase chain reaction

Y Fan, L Einhorn, S Saxman, B Katz, R Abonour, and K Cornetta
Clin Cancer Res 1998 4: 93 [Abstract] [PDF]  

Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues

TJ Kinsella, KA Kunugi, KA Vielhuber, DM Potter, ME Fitzsimmons, and JM Collins
Clin Cancer Res 1998 4: 99 [Abstract] [PDF]  

Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system

G Storm, MT ten Kate, PK Working, and IA Bakker-Woudenberg
Clin Cancer Res 1998 4: 111 [Abstract] [PDF]  

6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin

II Budihardjo, DL Walker, PA Svingen, CA Buckwalter, S Desnoyers, S Eckdahl, GM Shah, GG Poirier, JM Reid, MM Ames, and SH Kaufmann
Clin Cancer Res 1998 4: 117 [Abstract] [PDF]  

Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione

X Chen, RL Schecter, OW Griffith, MA Hayward, LC Alpert, and G Batist
Clin Cancer Res 1998 4: 131 [Abstract] [PDF]  

Bladder tissue uptake of mitomycin C during intravesical therapy is linear with drug concentration in urine

X Gao, JL Au, RA Badalament, and MG Wientjes
Clin Cancer Res 1998 4: 139 [Abstract] [PDF]  

Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression

AA Gibson, FG Harwood, DM Tillman, and JA Houghton
Clin Cancer Res 1998 4: 145 [Abstract] [PDF]  

Modulation of cancer chemotherapy by green tea

Y Sadzuka, T Sugiyama, and S Hirota
Clin Cancer Res 1998 4: 153 [Abstract] [PDF]  

A sensitive and specific radioimmunoassay for LY309887, a potent inhibitor of glycinamide ribonucleotide formyltransferase

DL Coleman, N Canak, GD Place, C Shih, and RR Bowsher
Clin Cancer Res 1998 4: 157 [Abstract] [PDF]  

In vivo toxicity and pharmacokinetic features of B43 (anti-CD19)-genistein immunoconjugate in nonhuman primates

Y Messinger, Y Yanishevski, O Ek, T Zeren, B Waurzyniak, R Gunther, L Chelstrom, M Chandan-Langlie, E Schneider, DE Myers, W Evans, and FM Uckun
Clin Cancer Res 1998 4: 165 [Abstract] [PDF]  

Antitumor activity of actinonin in vitro and in vivo

Y Xu, LT Lai, JL Gabrilove, and DA Scheinberg
Clin Cancer Res 1998 4: 171 [Abstract] [PDF]  

Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis

SJ Kim, E Shiba, T Kobayashi, E Yayoi, J Furukawa, Y Takatsuka, E Shin, H Koyama, H Inaji, and S Takai
Clin Cancer Res 1998 4: 177 [Abstract] [PDF]  

Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

VM Whitehead, MJ Vuchich, L Cooley, SJ Lauer, DH Mahoney, JJ Shuster, C Payment, ML Bernstein, JJ Akabutu, T Bowen, BA Kamen, MS Watson, AT Look, DJ Pullen, and B Camitta
Clin Cancer Res 1998 4: 183 [Abstract] [PDF]  

Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers

JP Peyrat, L Vanlemmens, J Fournier, G Huet, F Revillion, and J Bonneterre
Clin Cancer Res 1998 4: 189 [Abstract] [PDF]  

Genetic changes and telomerase activity in human renal cell carcinoma

V Rohde, HP Sattler, B Oehlenschlager, S Forster, T Zwergel, G Seitz, and B Wullich
Clin Cancer Res 1998 4: 197 [Abstract] [PDF]  

TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival

AL Borresen-Dale, RA Lothe, GI Meling, P Hainaut, TO Rognum, and E Skovlund
Clin Cancer Res 1998 4: 203 [Abstract] [PDF]  

Genetic abnormalities in parathyroid nodules of uremic patients

J Chudek, E Ritz, and G Kovacs
Clin Cancer Res 1998 4: 211 [Abstract] [PDF]  

Gene amplification as a prognostic factor in primary brain tumors

JJ Olson, D Barnett, J Yang, R Assietti, G Cotsonis, and CD James
Clin Cancer Res 1998 4: 215 [Abstract] [PDF]  

RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features

I Bongarzone, P Vigneri, L Mariani, P Collini, S Pilotti, and MA Pierotti
Clin Cancer Res 1998 4: 223 [Abstract] [PDF]  

Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma

K Yashima, S Milchgrub, LS Gollahon, A Maitra, MH Saboorian, JW Shay, and AF Gazdar
Clin Cancer Res 1998 4: 229 [Abstract] [PDF]  

Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1

H Aida, K Takakuwa, H Nagata, I Tsuneki, M Takano, S Tsuji, T Takahashi, T Sonoda, M Hatae, K Takahashi, K Hasegawa, H Mizunuma, N Toyoda, H Kamata, Y Torii, N Saito, K Tanaka, M Yakushiji, T Araki, and K Tanaka
Clin Cancer Res 1998 4: 235 [Abstract] [PDF]  

Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival

G Fontanini, M De Laurentiis, S Vignati, S Chine, M Lucchi, V Silvestri, A Mussi, S De Placido, G Tortora, AR Bianco, W Gullick, CA Angeletti, G Bevilacqua, and F Ciardiello
Clin Cancer Res 1998 4: 241 [Abstract] [PDF]  

Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression

RD Meng, H Shih, NS Prabhu, DL George, and WS el-Deiry
Clin Cancer Res 1998 4: 251 [Abstract] [PDF]  

Letters:

Correspondence Re: C. Caserini et al., Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies. Clin. Cancer Res., 3: 955-961, 1997

VR Bulusu
Clin Cancer Res 1998 4: 261 [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.